Keratoconus is present in ~1.2% of people in developed countries and up to ~7% in developing countries

Prevalence Of Keratoconus Based On Scheimpflug Imaging

the Raine Study

• 1.2% in 20 Year Olds (1:84)
• “…Important implications for screening … at a younger age so that treatment can be initiated before disease progression.”-ophthalmology, 2021

Malpractice suits have increased for failure to Diagnosis and promptly refer (e.g. progressive keratoconus) with this new information.
Suits on behalf of younger pts are much more likely to find against the doctor and result in larger Awards.

FALSE.

As with glaucoma or macular degeneration, ideal patient care would involve preventing loss of visual once the diagnosis is made if the risks of treatment are low.

FALSE.

“Keratoconus is [by definition] a bilateral and asymmetric disease which results in progressive thinning and steeping of the cornea leading to irregular astigmatism and decreased visual acuity”.

TRUE.

Corneas as thin as 301 and even 275 microns have been treated successfully without preoperative swelling using the Epithelium-On system described above.

FALSE.

Vision is what the patient is concerned about and it is poorly correlated with Kmax after CXL. The treated eyes with worse postoperative Kmax values actually saw better!